OCD and intractable-condition options widen
Deep brain stimulation, transcranial magnetic stimulation, and emerging psychedelic-assisted therapy are all reaching into refractory OCD.
Refractory obsessive-compulsive disorder has been a small but high-need population with limited options beyond intensive cognitive behavioural therapy and SSRIs. Deep brain stimulation has approval; transcranial magnetic stimulation now has an OCD-specific indication; psychedelic-assisted therapy programs are in early trials. The competitive question is which modality clears the operational and reimbursement bar for routine use first.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.